Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feedernews.google.com
HDAC6 inhibitor - Google News
Get the latest updates from HDAC6 inhibitor - Google News directly as they happen.
Follow now < 10 followers
Latest posts
Last updated over 3 years ago
Jubilant Therapeutics Inc. to Present Data on Isoform Selective PAD4 inhibitors in the Treatment of Cancer at the American Association of Cancer Research Annual (AACR) Meeting 2022 - Yahoo Finance
over 3 years ago
Jubilant Therapeutics Inc. to Present Data on Isoform Selective PAD4 inhibitors in...
Jubilant Therapeutics Inc. to Present Data on Isoform Selective PAD4 inhibitors in the Treatment of Cancer at the American Association of Cancer Research Annual (AACR) Meeting 2022 - PR Newswire
over 3 years ago
Jubilant Therapeutics Inc. to Present Data on Isoform Selective PAD4 inhibitors in...
Jubilant Therapeutics Inc. to Present Data on Isoform Selective PAD4 inhibitors in the Treatment of Cancer at the American Association of Cancer Research Annual (AACR) Meeting 2022 - Yahoo Finance
over 3 years ago
Jubilant Therapeutics Inc. to Present Data on Isoform Selective PAD4 inhibitors in...
Juvenile hormone-induced histone deacetylase 3 suppresses apoptosis to maintain larval midgut in the yellow fever mosquito - pnas.org
over 3 years ago
Juvenile hormone-induced histone deacetylase 3 suppresses apoptosis to maintain larval midgut in...
Wall Street high on LSD1; mid-stage, early trips underway - BioWorld Online
over 3 years ago
Wall Street high on LSD1; mid-stage, early trips underway BioWorld Online
The HDAC inhibitor GCJ-490A suppresses c-Met expression through IKKalpha and overcomes gefitinib resistance in non-small cell lung cancer - DocWire News
over 3 years ago
The HDAC inhibitor GCJ-490A suppresses c-Met expression through IKKalpha and overcomes gefitinib...
Hillstream BioPharma (HILS) Provides Business Review with Key Pipeline Updates - StreetInsider.com
over 3 years ago
Hillstream BioPharma (HILS) Provides Business Review with Key Pipeline Updates StreetInsider.com
Hillstream BioPharma Provides Business Review with Key Pipeline Updates - StreetInsider.com
over 3 years ago
Hillstream BioPharma Provides Business Review with Key Pipeline Updates StreetInsider.com
Histone Deacetylase Inhibitors Under Study in Bortezomib-Resistant Multiple Myeloma - Hematology Advisor
over 3 years ago
Histone Deacetylase Inhibitors Under Study in Bortezomib-Resistant Multiple Myeloma Hematology Advisor
Histone Deacetylase Inhibitors Under Study in Bortezomib-Resistant Multiple Myeloma - Hematology Advisor
over 3 years ago
Histone Deacetylase Inhibitors Under Study in Bortezomib-Resistant Multiple Myeloma Hematology Advisor
Hillstream BioPharma Announces Acceptance of Abstract at AACR 2022 Annual Meeting Highlighting HSB-510, a Novel Quatramer-based, First-in-Class Dual Inhibitor of HDAC6 and PI3K-delta Downregulating c- - StreetInsider.com
over 3 years ago
Hillstream BioPharma Announces Acceptance of Abstract at AACR 2022 Annual Meeting Highlighting...
Hillstream BioPharma Announces Acceptance of Abstract at AACR 2022 Annual Meeting Highlighting HSB-510, a Novel Quatramer-based, First-in-Class Dual Inhibitor of HDAC6 and PI3K-delta Downregulating c-myc Expression - Stockhouse
over 3 years ago
Hillstream BioPharma Announces Acceptance of Abstract at AACR 2022 Annual Meeting Highlighting...